Another study has also shown that receiving NAC (80 mg/kg, p.o.)for 7 weeks reduced caspase-3 levels and protects against nonalcoholic fatty liver disease in young rats (57). This evidence concerns the gene CASP3 and metabolic dysfunction-associated steatotic liver disease.